Status:
COMPLETED
Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples
Lead Sponsor:
Nanogen, Inc.
Conditions:
Congestive Heart Failure (CHF)
Eligibility:
All Genders
45+ years
Brief Summary
The primary objective of the study is to establish the correlation between NT-proBNP measurements in fresh human whole blood samples and those in plasma samples from the same study subjects, where sai...
Eligibility Criteria
Inclusion
- Have clinically confirmed heart failure (NYHA class I-IV) or have presented to an emergency room or clinic with signs, symptoms and/or risk factors suggestive of heart failure, OR
- Be non-CHF controls greater than 45 years of age with no history of heart failure or cardiovascular disease.
Exclusion
- Be 45 years of age or younger
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00734045
Start Date
February 1 2008
End Date
November 1 2008
Last Update
December 10 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
US Department of Veteran's Affairs
San Diego, California, United States, 92161
2
San Francisco General Hospital
San Francisco, California, United States, 94110